Late changes in cutaneous gene expression patterns after adjuvant treatment of oral squamous cell carcinoma (OSCC) by radiation therapy

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 5, 2010, Pages 694-699

  Mueller, Cornelia K ^a   Thorwarth, Michael ^a   Schultze Mosgau, Stefan ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; MMP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ADJUVANT THERAPY; AGED; ANGIOGENESIS; ARTICLE; BIOPSY; BONE TRANSPLANTATION; COMPARATIVE STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MANDIBLE TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASTIC SURGERY; RADIATION EXPOSURE; RADIATION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN TRANSPLANTATION; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

AGED; AGED, 80 AND OVER; BIOPSY; BONE TRANSPLANTATION; CARCINOMA, SQUAMOUS CELL; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MALE; MANDIBULAR NEOPLASMS; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOADJUVANT THERAPY; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RECONSTRUCTIVE SURGICAL PROCEDURES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN TRANSPLANTATION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 77951024665     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.10.030     Document Type: Article

References (28)

1. Guntinas-Lichius O., Wendt T., Buentzel J., Esser D., Lochner P., Mueller A., et al. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol (2009) Epub ahead of print
2. Bootz F., and Howaldt H.-.P. [Karzinome des oberen Aerodigestivtraktes]. In: Krebsgesellschaft D. (Ed). Kurzgefasste interdisziplinäre Leitlinien 2008 (2008), W. Zuckschwerdt Verlag, Munich 1-12
3. Kessler P., Grabenbauer G., Leher A., Bloch-Birkholz A., Vairaktaris E., and Neukam F.W. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma. Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46 1 (2008) 1-5
4. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 5 (1995) 1341-1346
5. Halle M., Bodin I., Tornvall P., Wickman M., Farnebo F., and Arnander C. Timing of radiotherapy in head and neck free flap reconstruction-a study of postoperative complications. J Plast Reconstr Aesthet Surg 62 7 (2009) 889-895
6. Mueller C.K., Schultze-Mosgau S., et al. Radiation-induced microenvironments-the molecular basis for free flap complications in the pre-irradiated field?. Radiother Oncol 93 (2009) 581-585
7. Evans G.R., Black J.J., Robb G.L., Baldwin B.J., Kroll S.S., Miller M.J., et al. Adjuvant therapy: the effects on microvascular lower extremity reconstruction. Ann Plast Surg 39 2 (1997) 141-144
8. Spierer M.M., Alektiar K.M., Zelefsky M.J., Brennan M.F., and Cordiero P.G. Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys 56 4 (2003) 1112-1116
9. Zimmerman R.P., Mark R.J., Kim A.I., Walton T., Sayah D., Juillard G.F., et al. Radiation tolerance of transverse rectus abdominis myocutaneous-free flaps used in immediate breast reconstruction. Am J Clin Oncol 21 4 (1998) 381-385
10. Diegmann J., Junker K., Gerstmayer B., Bosio A., Hindermann W., Rosenhahn J., et al. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Eur J Cancer 41 12 (2005) 1794-1801
11. Saeed A.I., Bhagabati N.K., Braisted J.C., Liang W., Sharov V., Howe E.A., et al. TM4 microarray software suite. Meth Enzymol 411 (2006) 134-193
12. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
13. Khoury F. [Komplikationen und Risiken bei augmentativen Maβnahmen]. In: Khoury F., Hanser T., Khoury C., Neugebauer T., Terpelle T., Tunkel J., et al. (Eds). [Augmentative Verfahren in der Implantologie] (2009), Quintessenz, Berlin 430-514
14. Bayat A., Bock O., Mrowietz U., Ollier W.E., and Ferguson M.W. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 13 2 (2004) 120-124
15. Brown J.J., Ollier W., Arscott G., Ke X., Lamb J., Day P., et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 17 7 (2008) 610-613
16. Copland J.A., Luxon B.A., Ajani L., Maity T., Campagnaro E., Guo H., et al. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 22 39 (2003) 8053-8062
17. Copland J.A., Davies P.J., Shipley G.L., Wood C.G., Luxon B.A., and Urban R.J. The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Rec Prog Horm Res 58 (2003) 25-53
18. Kuroda K., Okamoto O., and Shinkai H. Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen. J Invest Dermatol 112 5 (1999) 706-710
19. Okamoto O., Fujiwara S., Abe M., and Sato Y. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. Biochem J 337 Pt 3 (1999) 537-541
20. Catherino W.H., Leppert P.C., Stenmark M.H., Payson M., Potlog-Nahari C., Nieman L.K., et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chrom Cancer 40 3 (2004) 204-217
21. Schultze-Mosgau S., Wehrhan F., Rodel F., Amann K., Radespiel-Troger M., and Grabenbauer G.G. Transforming growth factor-beta receptor-II up-regulation during wound healing in previously irradiated graft beds in vivo. Wound Repair Regen 11 4 (2003) 297-305
22. Schultze-Mosgau S., Blaese M.A., Grabenbauer G., Wehrhan F., Kopp J., Amann K., et al. Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue. Radiother Oncol 70 3 (2004) 249-259
23. Pohlers D., Brenmoehl J., Loffler I., Muller C.K., Leipner C., Schultze-Mosgau S., et al. TGF-beta and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 1792 8 (2009) 746-756
24. Hikake T., Mori T., Iseki K., Hagino S., Zhang Y., Takagi H., et al. Comparison of expression patterns between CREB family transcription factor OASIS and proteoglycan core protein genes during murine tooth development. Anatom Embryol 206 5 (2003) 373-380
25. Nagarajan R.P., Chen F., Li W., Vig E., Harrington M.A., Nakshatri H., et al. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB. Biochem J 348 Pt 3 (2000) 591-596
26. Wehrhan F., Rodel F., Grabenbauer G.G., Amann K., Bruckl W., and Schultze-Mosgau S. Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing. Radiother Oncol 72 3 (2004) 297-303
27. Roy R., Zhang B., and Moses M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 312 5 (2006) 608-622
28. Seegenschmiedt M.H., Müller R.P., Höffken K., Junginger T., and Sauer H. [LENT-SOMA-Kriterien]. Dt ärztebl 97 37 (2000) 2395-2401